THE SIMMONS & RUSSELL GROUP, LLC for ELI LILLY AND COMPANY
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Issues related to Medicare Part D coverage and reimbursement policies. Issues related to Medicaid reimbursement. Issues related to drug pricing; Prescription Drug Pricing Reduction Act of 2019, S.2543.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROBERT A RUSSELL | — |
| KYLE SIMMONS | — |
Pharmacy PHA
Issues related to the pharmaceutical industry including drug pricing, drug value, and the 340B Program. Issues related to healthcare policy and cost; Lower Health Care Costs Act of 2019, S.1895. Healthcare issues related to the CARES Act, H.R.748, P.L.116-136 implementation and additional COVID-19 legislative proposals, Making consolidated appropriations for the fiscal year ending September 30, 2021, providing coronavirus emergency response and relief, and for other purposes, H.R.133, P.L.116-260.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROBERT A RUSSELL | — |
| KYLE SIMMONS | — |
Taxation/Internal Revenue Code TAX
Issues related to the implementation of the Tax Cuts and Jobs Act, P.L.115-97.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROBERT A RUSSELL | — |
| KYLE SIMMONS | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.